Syngene International Limited (SYNGENE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.010x

Based on the latest financial reports, Syngene International Limited (SYNGENE) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-451.00 Million ≈ $-4.88 Million USD) by net assets (Rs47.35 Billion ≈ $512.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Syngene International Limited (SYNGENE) defensive interval to measure how many days the company can operate on defensive assets alone.

Syngene International Limited - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Syngene International Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Syngene International Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syngene International Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dongguan Eontec Co Ltd SHE:300328	-0.047x
NagaCorp Ltd F:N9J	0.028x
Nyocor Co Ltd SHG:600821	0.138x
Borusan Mannesmann Boru Sanayi ve Ticaret AS IS:BRSAN	0.011x
Luenmei Quantum Co Ltd SHG:600167	0.009x
Entra ASA OL:ENTRA	0.054x
NCR Atleos Corporation NYSE:NATL	0.442x
PARK24 SPONS. ADR/1 F:3WN	N/A

Annual Cash Flow Conversion Efficiency for Syngene International Limited (2010–2025)

The table below shows the annual cash flow conversion efficiency of Syngene International Limited from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see SYNGENE stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs47.27 Billion ≈ $511.19 Million	Rs11.68 Billion ≈ $126.27 Million	0.247x	+0.93%
2024-03-31	Rs42.58 Billion ≈ $460.46 Million	Rs10.42 Billion ≈ $112.70 Million	0.245x	+5.62%
2023-03-31	Rs36.18 Billion ≈ $391.27 Million	Rs8.38 Billion ≈ $90.67 Million	0.232x	+31.61%
2022-03-31	Rs32.98 Billion ≈ $356.62 Million	Rs5.81 Billion ≈ $62.79 Million	0.176x	-29.16%
2021-03-31	Rs28.21 Billion ≈ $305.12 Million	Rs7.01 Billion ≈ $75.83 Million	0.249x	-20.14%
2020-03-31	Rs21.76 Billion ≈ $235.30 Million	Rs6.77 Billion ≈ $73.23 Million	0.311x	-2.83%
2019-03-31	Rs19.68 Billion ≈ $212.87 Million	Rs6.30 Billion ≈ $68.18 Million	0.320x	+23.48%
2018-03-31	Rs17.20 Billion ≈ $186.05 Million	Rs4.46 Billion ≈ $48.25 Million	0.259x	-7.85%
2017-03-31	Rs14.13 Billion ≈ $152.82 Million	Rs3.98 Billion ≈ $43.01 Million	0.281x	-5.15%
2016-03-31	Rs10.53 Billion ≈ $113.86 Million	Rs3.12 Billion ≈ $33.78 Million	0.297x	+1255.19%
2015-03-31	Rs8.45 Billion ≈ $91.37 Million	Rs185.00 Million ≈ $2.00 Million	0.022x	-95.18%
2014-03-31	Rs6.59 Billion ≈ $71.30 Million	Rs3.00 Billion ≈ $32.39 Million	0.454x	+127.62%
2013-03-31	Rs5.19 Billion ≈ $56.08 Million	Rs1.03 Billion ≈ $11.19 Million	0.200x	-51.53%
2012-03-31	Rs2.97 Billion ≈ $32.10 Million	Rs1.22 Billion ≈ $13.22 Million	0.412x	+13.87%
2011-03-31	Rs2.21 Billion ≈ $23.87 Million	Rs798.00 Million ≈ $8.63 Million	0.362x	-14.05%
2010-03-31	Rs1.94 Billion ≈ $20.93 Million	Rs814.00 Million ≈ $8.80 Million	0.421x	--

About Syngene International Limited

NSE:SYNGENE India Diagnostics & Research

Market Cap

$1.95 Billion

Rs180.09 Billion INR

Market Cap Rank

#6419 Global

#283 in India

Share Price

Rs448.30

Change (1 day)

-1.06%

52-Week Range

Rs389.90 - Rs722.05

All Time High

Rs947.80